<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01529346</url>
  </required_header>
  <id_info>
    <org_study_id>B3291009</org_study_id>
    <nct_id>NCT01529346</nct_id>
  </id_info>
  <brief_title>Efficacy Of PF-05089771 In Treating Postoperative Dental Pain</brief_title>
  <official_title>A Randomized, Double-Blind, Double-Dummy, Parallel Group, Placebo Controlled Study Assessing The Efficacy Of Single Doses Of PF-05089771 For The Treatment Of Postoperative Dental Pain Using Ibuprofen 400 mg As Positive Control</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pfizer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the overall pain relief of a single dose of
      PF-05089771 against placebo following third molar extraction.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total Pain Relief over the period from 0- 6 hr post dose (TOTPAR 6). TOTPAR 6 is defined as the area under the PR curve through the first 6 hours post-dosing.</measure>
    <time_frame>0-6 hr post dose</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Peak Pain relief (PPR)</measure>
    <time_frame>0-24 hr post dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time specific pain relief (PR)</measure>
    <time_frame>0-24 hr post dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time-specific Pain Intensity Difference (PID)</measure>
    <time_frame>0-24 hr post dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Summed Pain Intensity Difference (SPID)</measure>
    <time_frame>6 hr and 24 hr post dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Pain Relief TOTPAR[24] (area under the PR curve through the first 24 hr post dose).</measure>
    <time_frame>0-24 hr post dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to perceptible pain relief (PR). At the time of dosing with study medication, 2 stopwatches will be started. Subjects will be instructed to stop the first stopwatch at the time they feel any pain relieving effect.</measure>
    <time_frame>0-6 hr post dose.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to meaningful pain relief (PR). At the time of dosing with study medication, 2 stopwatches will be started. Subjects will be instructed to stop the second stopwatch when they feel the pain relief is meaningful to them.</measure>
    <time_frame>0-6 hr post dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient's Global Evaluation of Study Medication</measure>
    <time_frame>6 hr and 24 hr post dose and immediately prior to rescue medication.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction Questionnaire</measure>
    <time_frame>6 hr and 24 hr post dose and immediately prior to rescue medication.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pharmacokinetic (PK) profile of PF-05089771 and ibuprofen</measure>
    <time_frame>Day 0 (pre-dose), 30 min, 60 min, 2 hr, 4 hr, 6 hr, 8 hr, 10 hr and 24 hr post dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>Up to 28 days post dose.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety Lab tests</measure>
    <time_frame>Day -28 to Day 0;Day 0, Day 2, Day 7-10</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure and pulse rate</measure>
    <time_frame>Day -28 to Day 0, Day 1, Day 2, Day 7-10</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ECG</measure>
    <time_frame>Day -28 to Day0; 6 hr and 24 hr post dose, Day 7-10 if required</time_frame>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">235</enrollment>
  <condition>Postoperative Dental Pain</condition>
  <arm_group>
    <arm_group_label>PF-05089771 1600 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>PF-05089771 450 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>PF-05089771 150 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Ibuprofen 400 mg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PF-05089771</intervention_name>
    <description>A single dose of PF-05089771 1600 mg oral solution administered once to the subject on Day 1 postoperatively</description>
    <arm_group_label>PF-05089771 1600 mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo tablets for ibuprofen: 2 X 200 mg placebo tablets administered orally once to the subject on Day 1 postoperatively</description>
    <arm_group_label>PF-05089771 1600 mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PF-05089771</intervention_name>
    <description>A single dose of PF-05089771 450 mg oral solution administered once to the subject on Day 1 postoperatively</description>
    <arm_group_label>PF-05089771 450 mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo tablets for ibuprofen: 2 X 200 mg placebo tablets administered orally once to the subject on Day 1 postoperatively</description>
    <arm_group_label>PF-05089771 450 mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PF-05089771</intervention_name>
    <description>A single dose of PF-05089771 150 mg oral solution administered once to the subject on Day 1 postoperatively</description>
    <arm_group_label>PF-05089771 150 mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo tablets for ibuprofen: 2 X 200 mg placebo tablets administered orally once to the subject on Day 1 postoperatively</description>
    <arm_group_label>PF-05089771 150 mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen</intervention_name>
    <description>2 X 200 mg tablets of ibuprofen administered orally once to the subject on Day 1 postoperatively</description>
    <arm_group_label>Ibuprofen 400 mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo solution for PF-05089771: A single dose of Placebo solution administered once to the subject on Day 1 postoperatively</description>
    <arm_group_label>Ibuprofen 400 mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo solution for PF-05089771:A single dose of Placebo solution administered once to the subject on Day 1 postoperatively</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo tablets for Ibuprofen: 2 X 200 mg placebo tablets administered orally once to the subject on Day 1 postoperatively</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Oral surgery having removed 2 unilateral third molar teeth.

          -  Pre-dose pain intensity score (100 mm VAS [VAS]) of at least 50mm within 5 hours of
             oral surgery

          -  Pre-dose pain intensity score of moderate or severe within 5 hours of oral surgery

        Exclusion Criteria:

          -  Presence or known history of any clinically significant hematological, hepatic, renal,
             endocrine, cardiovascular, neurological, psychiatric, gastrointestinal, pulmonary,
             allergic (including known drug hypersensitivities or allergies, but excluding
             untreated asymptomatic seasonal allergy) or any metabolic disorder that may increase
             risk associated with study participation, investigational drug administration or may
             interfere with interpretation of study results.

          -  Prior use of any type of analgesic or NSAID within 5-half lives of that drug or less
             before taking the first dose of study medication, except for anesthesia for the
             procedure.

          -  Active dental infection at the time of surgery.

          -  Recent (within the previous 12 months) history of chronic analgesic or tranquiliser
             dependency.

          -  Any significant oral surgery complication at the time of surgery or in the immediate
             postoperative period, or oral surgery that has lasted more than 30 minutes (time from
             first incision to last suture placement).

        Subjects who smoke more than 1 pack (20 cigarettes) per day, more than 3 cigars per day or
        use smokeless tobacco on a daily basis are excluded from the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pfizer CT.gov Call Center</last_name>
    <role>Study Director</role>
    <affiliation>Pfizer</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78744</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=B3291009&amp;StudyName=Efficacy%20Of%20PF-05089771%20In%20Treating%20Postoperative%20Dental%20Pain</url>
    <description>To obtain contact information for a study center near you, click here.</description>
  </link>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 13, 2011</study_first_submitted>
  <study_first_submitted_qc>February 6, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 8, 2012</study_first_posted>
  <disposition_first_submitted>February 5, 2018</disposition_first_submitted>
  <disposition_first_submitted_qc>February 5, 2018</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">February 9, 2018</disposition_first_posted>
  <last_update_submitted>February 5, 2018</last_update_submitted>
  <last_update_submitted_qc>February 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Postoperative dental pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Toothache</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ibuprofen</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>February 21, 2018</submitted>
    <returned>March 21, 2018</returned>
    <submitted>May 25, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

